Active, not recruitingNot applicableNCT05915806

Enteral High-dose DHA Supplementation on Bronchopulmonary Dysplasia in Very Preterm Infants: a Collaborative Study

Studying Bronchopulmonary dysplasia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
CHU de Quebec-Universite Laval
Principal Investigator
Isabelle Marc, MD, PhD
CHU de Québec-Université Laval
Intervention
High-dose DHA(dietary_supplement)
Enrollment
1801 enrolled
Eligibility
All sexes
Timeline
2023 – 2026

Study locations (1)

Collaborators

Canadian Institutes of Health Research (CIHR) · Laval University · South Australian Health and Medical Research Institute · McGill University Health Centre/Research Institute of the McGill University Health Centre

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05915806 on ClinicalTrials.gov

Other trials for Bronchopulmonary dysplasia

Additional recruiting or active studies for the same condition.

See all trials for Bronchopulmonary dysplasia →

← Back to all trials